This educational supplement discusses updated treatment guidelines for bacterial vaginosis (BV) and reviews literature on the association of BV and the risk of sexually transmitted infections that supports the need for proper BV treatment, whether symptomatic or asymptomatic.
Download the supplement
HIV remission among children reported over 1 year after treatment interruption
March 7th 2024Research presented at the 2024 Conference on Retroviruses and Opportunistic Infections reveals that 4 children, treated with antiretroviral therapy within 48 hours of birth, have achieved over a year of HIV remission.
Read More
Dapivirine ring and oral PrEP found safe for preventing HIV in pregnant women
March 6th 2024Recent findings affirm the safety of monthly dapivirine vaginal rings and daily oral PrEP with tenofovir disoproxil fumarate and emtricitabine in preventing HIV transmission among pregnant cisgender women.
Read More
Study finds AI tool MySTIRisk effectively identifies high-risk STI subgroups
March 5th 2024A recent study revealed the effectiveness of the AI tool MySTIRisk in pinpointing high-risk subgroups for HIV and other sexually transmitted infections, shedding light on improved risk assessment and testing accessibility.
Read More